Walvax Biotechnology Co., Ltd. (SHE:300142)
10.00
-0.64 (-6.02%)
Nov 20, 2026, 3:04 PM CST
Walvax Biotechnology Market Cap
Walvax Biotechnology has a market cap or net worth of 15.99 billion as of November 20, 2026. It is the 5,590th most valuable company in the world and the 882nd biggest in China. Its market cap has decreased by 19.16% in one year.
Market Cap
15.99B
Enterprise Value
16.84B
Revenue
1.85B
Global Rank
Country Rank
#882 China
PE Ratio
734.21
ChartMarket Cap Chart
Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 15.99B, an increase of 17.30%. That is a compound annual growth rate of 1.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 15.99B | -8.34% |
| Dec 31, 2025 | 17.45B | -9.69% |
| Dec 31, 2024 | 19.32B | -48.62% |
| Dec 29, 2023 | 37.60B | -41.50% |
| Dec 30, 2022 | 64.27B | -28.12% |
| Dec 31, 2021 | 89.42B | 50.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Joincare Pharmaceutical Group Industry | 18.64B |
| Guangdong Zhongsheng Pharmaceutical | 18.54B |
| Shanghai Haoyuan Chemexpress | 18.13B |
| Betta Pharmaceuticals | 17.62B |
| Hybio Pharmaceutical | 17.30B |
| Kangmei Pharmaceutical | 17.15B |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 15.33B |
| China Resources Double-Crane Pharmaceutical | 15.31B |